Cancer-free Life Expectancy in Small Administrative Areas in Korea and Its Associations with Regional Health Insurance Premiums.
Health Policy
Health Status Disparities
Insurance
Life Expectancy
Neoplasms
Socioeconomic Factors
Journal
Journal of Korean medical science
ISSN: 1598-6357
Titre abrégé: J Korean Med Sci
Pays: Korea (South)
ID NLM: 8703518
Informations de publication
Date de publication:
01 Nov 2021
01 Nov 2021
Historique:
received:
24
03
2021
accepted:
06
09
2021
entrez:
2
11
2021
pubmed:
3
11
2021
medline:
17
2
2022
Statut:
epublish
Résumé
To determine the priorities and resource allocation of community cancer-related health policies, it is necessary to measure cancer-related health indicators and the burden of cancer by region. This study calculated the cancer-free life expectancy at the We used aggregate data from the 2008-2017 National Health Information Database provided by the National Health Insurance Service. Cancer-free life expectancy was calculated by applying Sullivan's method to mortality and cancer prevalence by age group and sex for the 10-year period in 3,396 Cancer-free life expectancy in This study showed a significant regional gap with regard to cancer-free life expectancy and the burden of cancer at the
Sections du résumé
BACKGROUND
BACKGROUND
To determine the priorities and resource allocation of community cancer-related health policies, it is necessary to measure cancer-related health indicators and the burden of cancer by region. This study calculated the cancer-free life expectancy at the
METHODS
METHODS
We used aggregate data from the 2008-2017 National Health Information Database provided by the National Health Insurance Service. Cancer-free life expectancy was calculated by applying Sullivan's method to mortality and cancer prevalence by age group and sex for the 10-year period in 3,396
RESULTS
RESULTS
Cancer-free life expectancy in
CONCLUSION
CONCLUSIONS
This study showed a significant regional gap with regard to cancer-free life expectancy and the burden of cancer at the
Identifiants
pubmed: 34725977
pii: 36.e269
doi: 10.3346/jkms.2021.36.e269
pmc: PMC8560318
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e269Subventions
Organisme : Korea Health Industry Development Institute
ID : HI18C0446
Pays : Republic of Korea
Organisme : National Research Foundation of Korea
ID : NRF-2020R1I1A1A01066101
Pays : Korea
Informations de copyright
© 2021 The Korean Academy of Medical Sciences.
Déclaration de conflit d'intérêts
The authors have no potential conflicts of interest to disclose.
Références
Am J Public Health. 2010 May;100(5):896-903
pubmed: 20299661
Yonsei Med J. 2020 Jul;61(7):640-643
pubmed: 32608209
J Korean Med Sci. 2020 Nov 16;35(44):e365
pubmed: 33200592
J Korean Med Sci. 2017 Nov;32(11):1764-1770
pubmed: 28960027
J Korean Med Sci. 2017 Dec;32(12):1974-1983
pubmed: 29115079
Value Health. 2015 Jan;18(1):61-6
pubmed: 25595235
Epidemiol Health. 2017 Mar 15;39:e2017011
pubmed: 28330335
Popul Health Metr. 2020 Jul 3;18(1):3
pubmed: 32620133
BMJ Open. 2019 Jul 3;9(7):e030683
pubmed: 31272989
J Korean Med Sci. 2018 Nov 02;34(Suppl 1):e88
pubmed: 30923491
J Epidemiol Community Health. 2005 Feb;59(2):115-20
pubmed: 15650142
J Korean Med Sci. 2018 Nov 27;34(Suppl 1):e91
pubmed: 30923494
J Prev Med Public Health. 2020 Mar 05;:
pubmed: 32172547
Br J Cancer. 2005 Jan 31;92(2):241-5
pubmed: 15655548
Lancet. 2012 Dec 15;380(9859):2144-62
pubmed: 23245606
J Korean Med Sci. 2016 Nov;31 Suppl 2:S139-S145
pubmed: 27775251
Eur J Public Health. 2019 Apr 1;29(2):225-231
pubmed: 30260368
Health Qual Life Outcomes. 2020 Feb 27;18(1):45
pubmed: 32103763
J Korean Med Sci. 2019 Jun 17;34(23):e168
pubmed: 31197985
J Korean Med Sci. 2021 Jan 11;36(2):e8
pubmed: 33429472
JAMA Oncol. 2017 Apr 1;3(4):524-548
pubmed: 27918777
JAMA. 2016 Apr 26;315(16):1750-66
pubmed: 27063997